We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$1.34T
AUM Growth
+$27B
Cap. Flow
+$6.32B
Cap. Flow %
0.47%
Top 10 Hldgs %
24.3%
Holding
7,917
New
510
Increased
3,353
Reduced
2,466
Closed
523

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.21B
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$2.24B
3
DIS icon
Walt Disney
DIS
+$2.18B
4
WMT icon
Walmart Inc
WMT
+$1.96B
5
MCD icon
McDonald's
MCD
+$1.91B

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Financials 10.11%
3 Consumer Discretionary 9.84%
4 Healthcare 7.97%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCT
7651
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-1,111
Closed -$1.47K
MTEM
7652
DELISTED
Molecular Templates, Inc.
MTEM
-37
Closed -$52
BIOR
7653
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-2
Closed -$11
XELA
7654
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-245
Closed -$505
ARC
7655
DELISTED
ARC Document Solutions, Inc.
ARC
-84
Closed -$284
ATIP
7656
DELISTED
ATI Physical Therapy, Inc.
ATIP
-31
Closed -$189
LBPH
7657
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-97,995
Closed -$3.27M
VSTO
7658
DELISTED
Vista Outdoor Inc.
VSTO
-141,698
Closed -$5.55M
VZIO
7659
DELISTED
VIZIO Holding Corp.
VZIO
-65,570
Closed -$732K
PRLHU
7660
DELISTED
Pearl Holdings Acquisition Corp Unit
PRLHU
-1
Closed -$11
EQC.PRD
7661
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
-770
Closed -$19.4K
IBMM
7662
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
-2,000
Closed -$52.2K
CMAX
7663
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
-54
Closed -$92
BLEU
7664
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
-1
Closed -$11
ENV
7665
DELISTED
ENVESTNET, INC.
ENV
-2,274,581
Closed -$142M
ENV
7666
PUT
DELISTED
ENVESTNET, INC.
ENV
-2,500
Closed -$157K

Similar funds

JP Morgan Chase's Q4 2024 Portfolio in Review

As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.

JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
  • JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
  • JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
  • JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
  • JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
  • JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
  • JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.